The genome of picornaviruses, of which encephalomyocarditis virus (EMCV) is a member, is a single-stranded, positivesense RNA of about 7,500 to 8,300 nucleotides (2) . Picornavirus RNA is functionally monocistronic and, upon infection, is translated into a single polyprotein that is processed to yield structural and nonstructural virus proteins (49) . EMCV polyprotein processing is performed solely by the 3C protease (3C pro ), except for the first cotranslational autoproteolytic cleavage at the 2A/2B junction (20, 38) .
Infection with most picornaviruses is characterized by a strong inhibition of host cell protein synthesis at a time when virus-specific proteins are efficiently produced (reviewed in reference 9). Enteroviruses and rhinoviruses inhibit host translation, at least partially, by inactivation of eukaryotic translation initiation factor 4F (eIF4F), which binds to the cap structure of cellular mRNAs. eIF4F is composed of three polypeptides: eIF4E, eIF4A, and eIF4G (formerly p220). eIF4E is the cap-binding subunit (51) . eIF4A possesses RNA-dependent ATPase activity and, in association with eIF4B, exhibits bidirectional RNA helicase activity (47, 48) . eIF4G serves as a scaffold to bring together eIF4E, eIF4A, and eIF3 and bridges the mRNA and the ribosome (22) . Picornavirus RNAs are naturally uncapped and translate by a cap-and eIF4E-independent mechanism, by which the ribosomes bind to an IRES (internal ribosome entry site) (1, 2, 24) . Enteroviruses and rhinoviruses disrupt eIF4F by cleavage of the eIF4G subunit by 2A
pro . This cleavage has been reported to be direct (18, 28) or indirect (60) . eIF4G cleavage does not preclude but, rather, stimulates cap-independent initiation of viral protein synthesis, since the cap-binding subunit, eIF4E, remains associated with the N-terminal cleavage product (5, 28) . The C-terminal cleavage fragment of eIF4G interacts with eIF4A and eIF3 to support IRES-dependent, but not cap-dependent, translation initiation (5, 37, 46) . In contrast to enteroviruses and rhinoviruses, no cleavage of eIF4G occurs following infection of cells with cardioviruses, such as EMCV (36) . Also, the 2A protein of EMCV is not similar to the enterovirus and rhinovirus 2A pro and does not possess protease consensus motifs or detectable proteolytic activity (31) . It has long been assumed that the shutoff of host cell protein synthesis after EMCV infection results from the ability of viral RNA to efficiently compete with capped cellular mRNAs for some limiting component of the translational machinery (27, 53) . Recently, it was suggested that EMCV causes the shutoff of host translation by dephosphorylation and activation of a suppressor of cap-dependent translation, 4E-BP1 (eIF4E-binding protein 1) (14) . 4E-BP1 in its underphosphorylated form binds to eIF4E and inhibits its association with eIF4G (17, 32) . 4E-BP1 does not inhibit capindependent translation, such as that of picornaviruses, since this translation is independent of eIF4E (42). Another possible mechanism, which is not mutually exclusive, is the dephosphorylation of eIF4E (25) .
Phosphorylation of 4E-BP1 is decreased by rapamycin and wortmannin, which inhibit the phosphatidylinositol 3-kinase (PI3 kinase)-FKBP-rapamycin-associated protein (FRAP) signal transduction pathway (3, 29, 57) . PI3 kinase is activated by growth factors and hormones to deliver cell proliferation and survival signals. Upon activation, PI3 kinase phosphorylates the D3 position of PIs, which then act as second messengers to effect the different functions of PI3 kinase (reviewed in reference 12). Wortmannin inhibits PI3 kinase by binding irreversibly to its catalytic subunit (56) . The immunosuppressive drug rapamycin is a potent inhibitor of FRAP (mTOR/RAFT), a member of the phosphatidylinositol kinase-related family, which is thought to be a downstream target of PI3 kinase (reviewed in reference 7).
Rapamycin augments the shutoff of host cell protein synthe-sis and the rate of synthesis of viral proteins after infection with poliovirus and EMCV (4), presumably because it inhibits capdependent translation, and thus confers an advantage to the viral mRNA. However, the observed effect of rapamycin is modest, probably because both EMCV and poliovirus replicate rapidly. To further explore this phenomenon, we wished to study the effect of rapamycin and wortmannin on the replication of a debilitated EMCV strain. We used EMCV mutants harboring deletions in the 2A coding region. These mutants were generated originally in an effort to determine whether 2A is required for virus replication. The deletions in 2A did not affect virus viability but greatly reduced the growth of the virus in BHK-21 cells. Translation of the mutant virus was inefficient, and the shutoff of host cell protein synthesis was significantly mitigated. Translation of viral mRNA was restored to its wild-type level and the shutoff of host cell protein synthesis was dramatically enhanced by rapamycin and wortmannin. Thus, inhibition of the PI3 kinase-FRAP pathway could be a useful tool in studying the replication of slow-growing and defective picornaviruses.
ature. The cells were pelleted by centrifugation and suspended in 10 ml of Eagle's medium (GIBCO) supplemented with 0.1% glucose, 0.15% sodium bicarbonate, and 50 U each of penicillin and streptomycin per ml. The cells were maintained in suspension (10 7 cells/ml) at 37°C for 24 h. After incubation, the cells were subjected to three cycles of freezing and thawing. The virus was passaged two more times in Krebs-2 cells, using a multiplicity of infection (MOI) of 0.1 TCID 50 per cell, aliquoted, and stored at Ϫ70°C. To obtain ⌬2A or ⌬2A* EMCV for the purpose of viral RNA isolation, the infection was performed in the presence of 50 ng of rapamycin per ml and 1 M wortmannin.
Metabolic labeling. BHK-21 cells at 90 to 100% confluency in 35-mm petri dishes were infected with wild-type or 2A mutant EMCV at MOI of about 10 TCID 50 /cell in 0.5 ml of serum-free DMEM. After 30 min of adsorption at room temperature, the virus inoculum was removed by aspiration. The cells were washed once with methionine-free DMEM and incubated in 1 ml of methioninefree DMEM in the absence or presence of 50 ng of rapamycin per ml, 1 g of wortmannin per ml, or a combination of the two drugs. The cells were labeled with [ 35 S]methionine (50 Ci/ml) at 37°C for 30 min for different periods. They were lysed by being suspended in 0.5 ml of sample buffer and heated at 95°C for 8 min. Lysates from equal numbers of cells were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (15% polyacrylamide). After electrophoresis, the gels were processed for fluorography with En 3 Hance (Dupont).
Isolation of EMCV RNA. EMCV RNA was extracted from virus purified by the method of Chumakov (8) with some modifications. The crude EMCV suspension (200 ml) was supplemented with 0.01 volume of 10% Nonidet P-40 and clarified by low-speed centrifugation. Then 0.1 volume of protamine sulfate (10 mg/ml) was added to the suspension, and the precipitate was discarded. The virus was further purified and concentrated by centrifugation at 26,000 rpm for 4 h through a 5-ml cushion containing 30% sucrose in 1 M NaCl-0.02 M Tris-HCl (pH 7.5) in an SW27 rotor. The virus was suspended in 5 ml of STMS buffer (0.1 M NaCl, 50 mM Tris-HCl [pH 7.5], 14 mM ␤-mercaptoethanol, 1% SDS). Polyethylene glycol 6000 as a 30% solution was added to the virus suspension to a final concentration of 5%. The precipitated virus was pelleted at 10,000 ϫ g for 10 min. RNA from the purified virus preparation was extracted with phenol-chloroform-isoamyl alcohol (25:24:1) and purified by sucrose density gradient centrifugation (52, 55) .
Assays. EMCV RNA was translated in a rabbit reticulocyte lysate (12.5 l) (Promega) in the presence of [ 35 S]methionine at 30°C as recommended by the manufacturer. Translation products were analyzed on SDS-15% polyacrylamide gels as described above. Western blot analysis of 4E-BP1 was performed as described previously (14) .
RESULTS
Construction and characterization of EMCV 2A deletion mutants. Two deletions were introduced into the 2A coding region of the infectious EMCV cDNA. One deletion, ⌬2A (deletion of 58 of the 143 amino acids), eliminated an internal one-third of the 2A coding region, while another, ⌬2A* (deletion of 120 amino acids), removed most of the 2A sequence (Fig. 1) . Transfection of Krebs-2 cells with wild-type in vitrotranscribed RNA resulted in efficient virus production (titer of approximately 3 ϫ 10 9 TCID 50 /ml) and complete cell lysis within 24 h. Transfection of cells with mutant RNAs generated infectious viruses but with a low yield (ϳ10 7 TCID 50 /ml), and most of the cells were alive after 24 h. Recovered mutant viruses also exhibited a small-plaque phenotype when assayed on HeLa cell monolayers (data not shown). In BHK-21 cells, the mutants also replicated more slowly and to lower titers than did wild-type EMCV (see below).
Analysis of viral protein synthesis in vivo. To determine which step of EMCV replication was affected by the mutations in 2A, protein synthesis in infected BHK-21 cells was examined. Cells were pulse-labeled with [ 35 S]methionine 4.5 h postinfection, and extracts were analyzed by SDS-PAGE. Host cell protein synthesis was strongly inhibited, while the synthesis of viral proteins was efficient in wild-type-EMCV-infected cells ( Fig. 2A , compare lane 2 to lane 1). However, infection with ⌬2A or ⌬2A* viruses had little effect on host cell protein synthesis (compare lanes 6 and 10 to lane 1). All proteins of mutant viruses were synthesized in much smaller amounts than those of wild-type virus (compare lanes 6 and 10 to lane 2). As anticipated, no 2A protein could be detected in either ⌬2A or ⌬2A* EMCV-infected cells.
We recently demonstrated that EMCV infection of Krebs-2 cells led to inhibition of phosphorylation of 4E-BP1 and that the decreased phosphorylation of 4E-BP1 coincided with the shutoff of host cell protein synthesis (14) . Phosphorylation of 4E-BP1 is also inhibited by rapamycin and wortmannin, which block the PI3 kinase-FRAP signal transduction pathway (3, 29, 57) . In EMCV-infected NIH 3T3 cells, the expression of viral proteins was augmented by rapamycin (4). It was therefore possible that rapamycin and wortmannin were able to rescue the replication of viruses defective in the shutoff of host protein synthesis. To test this, BHK-21 cells were infected with EMCV in the presence of rapamycin or wortmannin or both. With wild-type EMCV, the effects of rapamycin and wortmannin on viral protein synthesis were minimal, probably because the shutoff of host translation and the induction of viral protein synthesis were already evident at the time of the labeling-4.5 h postinfection ( combination of the drugs was additive (lanes 9 and 13). As judged by the accumulation of the 2B polypeptide, which is generated by the first cleavage of the polyprotein (20, 40) , the combination of rapamycin and wortmannin stimulated protein synthesis of ⌬2A and ⌬2A* EMCV by 21-and 16-fold, respectively, while the stimulation with wild-type virus was less than 2-fold (Fig. 2B) .
A time course of virus protein synthesis shows that ⌬2A EMCV protein synthesis was enhanced by rapamycin and wortmannin to attain wild-type levels at all times of infection (Fig. 3) . Also, the drugs partially restored the ability of the mutant virus to induce the shutoff of host translation. In contrast, in wild-type-virus-infected cells, viral protein synthesis was enhanced by rapamycin and wortmannin only early (3 h) after infection, when the shutoff of host protein synthesis and induction of viral protein synthesis were not fully manifested (Fig. 3A) .
Next, we wished to determine whether dephosphorylation of 4E-BP1 correlates with the shutoff of host protein synthesis after infection with mutant EMCV; to do this, we used Western analysis. Three bands of 4E-BP1 were detected in mockinfected cells (Fig. 4, lane 1) . Considering earlier reports, the bottom band (␣) is hypophosphorylated compared to the top and middle bands (␤ and ␥) (3, 14, 29) . Mock-infected cells contained the hyperphosphorylated form of 4E-BP1 (form ␥, lane 1), but infection with wild-type EMCV resulted in its disappearance due to its conversion to the less phosphorylated forms (forms ␣ and ␤; compare lane 2 to lane 1). In contrast, ⌬2A EMCV infection failed to change the ratio of the 4E-BP1 isoforms (compare lane 3 to lane 1). Similarly, the relative amounts of 4E-BP1 forms were not appreciably changed following ⌬2A* EMCV infection (data not shown). These results provide additional evidence that the phosphorylation status of 4E-BP1 positively correlates with the level of host cell protein synthesis after EMCV infection. In a control experiment, rapamycin and wortmannin at the concentrations used in virus infections decreased 4E-BP1 phosphorylation as early as 30 min after exposure of cells to the drugs (compare lanes 5 and 6 to lane 4). The dephosphorylation was, however, not complete in either case.
Effects of rapamycin and wortmannin on virus growth. Considering the above results, it was pertinent to determine whether rapamycin and wortmannin could also rescue the growth of EMCV mutants. The effects of rapamycin and wortmannin on virus yield were determined by using a TCID 50 assay. Rapamycin and wortmannin each had a small effect (ϳ1.5-to 2-fold) on the yield of wild-type virus (Fig. 5A) . When used together, the drugs had an additive effect and increased the virus yield by threefold. The reason for this is not immediately clear, since rapamycin is known to inhibit only a subset of the phosphorylation events inhibited by wortmannin. We do not have an immediate explanation for the additive effect of the drugs, since both are supposed to act through the same pathway. ⌬2A and ⌬2A* EMCV yields were lower by 10 3 -and 10 2 -fold, respectively, than that of wild-type EMCV. Rapamycin and wortmannin increased mutant virus yield 3-to 10-fold, being especially effective with ⌬2A EMCV. When the drugs were used in combination, their stimulatory effect was additive, yielding 21-and 9-fold more virus with ⌬2A and ⌬2A* EMCV, respectively. Thus, rapamycin and wortmannin preferentially stimulate the replication of mutant viruses over wild-type EMCV. However, the mutant virus production could not be fully restored by the drugs, and the titers of ⌬2A and ⌬2A* EMCV were considerably lower than those of the wild-type virus under all conditions examined. It is noteworthy that to induce a cytopathic effect, some slow mutant cardioviruses require more infecting viral particles than wild-type viruses do (61) . Thus, the titers for 2A EMCV mutants shown in Fig. 5 could be underestimates.
⌬2A and ⌬2A* EMCV RNAs are deficient in reinitiating translation in vitro. To address the question why EMCV protein synthesis is compromised by mutations in 2A, the translation of wild-type and mutant EMCV RNAs in a rabbit reticulocyte lysate were compared. EMCV RNA is translated efficiently in a rabbit reticulocyte lysate, and 3C
pro /3ABC-mediated polyprotein processing takes place in this system to generate an almost complete set of mature viral proteins (23, 39, 44) . No difference in translation between wild-type and ⌬2A EMCV RNA was observed after a short (up to 20-min) incubation (Fig. 6A) . However, during a longer incubation, incorporation of [
35 S]methionine into protein, directed by wild-type EMCV RNA, was higher (up to 1.6-fold) than that directed by ⌬2A EMCV RNA (Fig. 6A) . At late times (e.g., 2 h), almost all virus-specific polypeptides accumulated in higher amounts in wild-type than in ⌬2A EMCV RNA-programmed translations (Fig. 6B) . A noticeable exception was P1-2A, which was less abundant than the P1-⌬2A counterpart. This probably reflects a more efficient cleavage of P1-2A than of P1-⌬2A (see below). A similar pattern was observed with ⌬2A* EMCV RNA (Fig. 6C) . Thus, both deletions within the 2A coding region impair viral translation in vitro.
Polyprotein processing is affected by deletions in 2A. In addition to viral protein synthesis, processing of the capsid precursor polypeptide, P1-2A, is affected by the deletions in 2A. P1-⌬2A and P1-⌬2A* accumulated in higher amounts than did wild-type P1-2A (Fig. 2A , compare lanes 9 and 13 to lane 5; Fig. 3 , compare lane 4 to lane 6). Concomitantly, mature virus proteins (1AB, 1D, and 1C) were generated more slowly for mutant EMCV than for wild-type EMCV. In the in vitro translation system, P1-⌬2A and P1-⌬2A* were also more stable than P1-2A ( Fig. 6B and C) . It is possible that P1-⌬2A and P1-⌬2A* are less susceptible to proteolysis than P1-2A. Alternatively, the failure of mutant capsid precursors to be efficiently processed could merely reflect low levels of 3C pro . To distinguish between these two possibilities, wild-type, ⌬2A and ⌬2A* EMCV RNAs were translated in a rabbit reticulocyte lysate for a short period (25 min) in the absence or presence of purified 3C
pro from mengovirus. In the absence of 3C pro , the polypeptides L-P1-2A and 2C were synthesized, but not 3C pro or 3ABC, which are responsible for polyprotein processing (23, 39, 41, 54) , or any other P3-derived polypeptides (Fig. 7) . In the presence of exogenous 3C pro (conditions which mimic those existing in virus-infected cells), the largest polypeptide synthesized was P1-2A (lane 2), which suggests that the leader peptide was rapidly cleaved off, apparently from the nascent polypeptide chain. Mutations in 2A affected neither this cotranslational cleavage of the leader peptide (compare lanes 2, 4, and 6) nor its cleavage from the presynthesized L-P1-2A precursor polypeptide (data not shown). However, subsequent processing of P1-2A, i.e., the cleavage at the P1/2A junction, was markedly diminished by the mutations. While the wildtype P1-2A was cleaved to a significant extent by 3C pro into P1, 1ABC, 1AB, 1D, 1C, and 2A (lane 2), only a minute fraction of P1-⌬2A or P1-⌬2A* was converted to characteristic cleavage products within the same period (lanes 4 and 6) . Thus, P1-⌬2A and P1-⌬2A* are less susceptible to cleavage by cardiovirus 3C pro than is wild-type P1-2A.
DISCUSSION
eIF4G serves as an adapter between mRNA and ribosomes and functions in both cap-dependent and cap-independent (22, 43, 45) . Recently, a new homolog of eIF4G (termed eIF4GII) was identified which functions in a manner similar to the original isoform (termed eIF4GI) (16) . eIF4G recruitment to capped mRNA is facilitated by its interaction with the cap-binding protein eIF4E. This interaction is regulated by a group of suppressor proteins, the 4E-BPs (30, 42) . When bound to mRNA, eIF4G facilitates the binding of the 43S preinitiation complex to the mRNA, most probably through protein-protein interactions with the ribosome-associated eIF3 (26, 37) . eIF4G also interacts with eIF4A, which, in conjunction with eIF4B, is thought to unwind the 5Ј mRNA secondary structure.
To switch from translation of cellular mRNAs to efficient production of viral proteins, picornaviruses have evolved strategies to usurp eIF4G. Enteroviruses, rhinoviruses, and aphthoviruses encode proteases that cleave eIF4G to generate two fragments. The C-terminal fragment retains the capacity to interact with IRES elements, as well as with eIF3 and eIF4A, and is sufficient to promote cap-independent translation (5, 6, 37, 46) . However, it lacks the eIF4E-binding site and is unable to support cap-dependent translation. Cardioviruses, as exemplified by EMCV, appear to affect eIF4G function in a different manner, namely, by inducing dephosphorylation and activation of 4E-BP1 (14) . The dephosphorylated form of 4E-BP1 sequesters eIF4E into an inactive eIF4E-4E-BP1 complex (17) and thus inhibits the eIF4E-eIF4G interaction.
While protein synthesis of ⌬2A EMCV in vivo is very inefficient relative to that of wild-type virus (Fig. 2) , the translation of ⌬2A virus mRNA in vitro is only ϳ40% less efficient than that of the wild-type virus (Fig. 6A) . This raises the possibility that the major effect of 2A deletion is not on translation but on some other steps of virus replication, such as viral RNA synthesis. An alternative interpretation, which we favor, is that the effect of 2A deletion is to attenuate virus mRNA translation in the cell, because rapamycin and wortmannin, which rescue viral protein synthesis, are known to affect the activity of translation initiation factors (3, 51, 57) . The effect of 2A deletion could be either a cis effect, which would incapacitate the template, or a trans effect, whereby 2A protein would be required for virus mRNA translation. Since translation in vitro is not dramatically affected by the deletion of 2A, it is unlikely that the effect is in cis. It is thus conceivable that 2A is required for efficient translation of EMCV RNA in vivo to counteract the competition from cellular mRNAs. In contrast, in a nucleasetreated rabbit reticulocyte lysate, there is no competition from cellular mRNAs, and therefore translation of ⌬2A EMCV RNA is less compromised. Addition of rapamycin and wortmannin, which inhibit capped-mRNA translation, would mitigate the competition and thus rescue ⌬2A EMCV RNA translation.
The state of 4E-BP1 phosphorylation correlates with the efficiency of viral protein synthesis after EMCV infection (Fig.  4) . The deletions in 2A, which abolished virus-induced 4E-BP1 dephosphorylation and inhibition of host cell protein synthesis, were also detrimental for the synthesis of viral proteins and resulted in a low virus yield (Fig. 2, 3, and 5 ). Rapamycin and wortmannin, which induce 4E-BP1 dephosphorylation, enhanced the replication of a defective virus. Thus, infection by a defective cardiovirus was significantly augmented by drugs that decrease 4E-BP1 phosphorylation. It should be noted, however, that other translation targets of the PI3 kinase pathway do exist (e.g., p70 S6 kinase and eIF2B) and could play a significant role in the phenomenon seen here (12, 59) . In addition, the concentration of wortmannin used here (1 M) is known to affect the mitogen-activated protein kinase pathway (10) , which affects eIF4E phosphorylation (11, 13, 58) . Inhibition of eIF4E phosphorylation leads to a decrease in cellular mRNA translation.
The reason why ⌬2A EMCV is deficient in inducing 4E-BP1 dephosphorylation is not known. Perhaps 2A, either directly or indirectly, inhibits signaling through the PI3 kinase-FRAP pathway or somehow activates phosphatases targeting 4E-BP1. Alternatively, the lack of 4E-BP dephosphorylation following ⌬2A EMCV infection could be a secondary effect resulting from inefficient virus replication and limited production of a protein other than 2A.
What is the nature of the impediments to efficient EMCV replication imposed by the deletions in 2A? Clearly, 2A disruption inhibits processing of the P1-2A precursor polypeptide. The 2A deletion mutants exhibited higher accumulation of the uncleaved P1-2A and less efficient formation of the mature capsid proteins than the wild-type EMCV ( Fig. 2A and  3) . Although the primary cotranslational cleavage at the 2A/2B junction (which results from an inherent instability of the corresponding peptide chain [20] ) remained unaffected, the P1/2A cleavage by 3C
pro was significantly slowed both in vitro and in vivo ( Fig. 2A, 3 , 6B and C, and 7). It is not immediately clear why an intact amino acid sequence of 2A is important for efficient cleavage. The slow processing of the P1-2A junction in 2A mutants would leave some of the 2A fragments associated with VP1 and might hinder the proper assembly of capsids. This processing defect could account for the failure of rapamycin and wortmannin to fully restore mutant virus production, despite the potent activity of these drugs in rescuing virus-specific translation.
2A might also function as a positive regulatory factor in virus-specific translation and/or RNA replication. With respect to translation control, a minimal set of factors required for 48S initiation complex formation with EMCV RNA has recently been defined by using a reconstituted ribosome-binding system (45) . No viral proteins are absolutely required for the activity of the EMCV IRES, since it functions efficiently in vivo with heterologous reporter sequences (6, 35) . EMCV RNA is also translated early in infection and before any appreciable accumulation of viral products. However, although 2A is not critical for the IRES activity, it might facilitate its function. For example, 2A could bind to the IRES and stabilize an active conformation. Consistent with this proposal is the finding that EMCV 2A is basic and binds RNA (15) . Moreover, a fraction of 2A is associated with ribosomes in virus-infected cells (33) . However, evidence that 2A functions as a virus-specific translation factor is clearly lacking for EMCV. In addition, IRES activity and inhibition of host cell protein synthesis could be regulated by other viral proteins, for example, by the leader peptide (L), as was suggested for mengovirus (61) . However, since the coding region of L is positioned very close to the IRES, it remains to be demonstrated that the contribution of the L sequences to efficient viral replication resides within the protein rather than within the RNA. Surprisingly, the 2A protein of Theiler's murine encephalomyelitis virus, another cardiovirus, has been reported to be dispensable for RNA replication or virus production in BHK-21 cells (34) . However, the 2A protein of Theiler's murine encephalomyelitis virus diverges remarkably from that of EMCV and therefore could be involved in some other processes of the virus life cycle.
Finally, our results suggest that rapamycin and other immunosuppressive drugs with potential clinical applicability should be evaluated with respect to their ability to target 4E-BP1 and activate latent infections caused by viruses that use an internal ribosome entry mechanism.
